Last $0.16 USD
Change Today +0.01 / 6.67%
Volume 302.6K
MZEI On Other Exchanges
Symbol
Exchange
OTC BB
Berlin
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

medizone international inc (MZEI) Snapshot

Open
$0.15
Previous Close
$0.15
Day High
$0.17
Day Low
$0.14
52 Week High
04/22/14 - $0.29
52 Week Low
01/13/14 - $0.05
Market Cap
54.1M
Average Volume 10 Days
165.0K
EPS TTM
--
Shares Outstanding
338.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDIZONE INTERNATIONAL INC (MZEI)

Related News

No related news articles were found.

medizone international inc (MZEI) Related Businessweek News

No Related Businessweek News Found

medizone international inc (MZEI) Details

Medizone International, Inc. designs, manufactures, and sells ozone disinfection systems in the United States. It offers AsepticSure hospital disinfection system, which is used in decontaminating and sterilizing hospital surgical suites, emergency rooms, and intensive care units, as well as other enclosed spaces, such as gym locker rooms, laboratories, and veterinary clinics. The company was founded in 1986 and is based in Sausalito, California.

4 Employees
Last Reported Date: 02/28/14
Founded in 1986

medizone international inc (MZEI) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $195.0K
President, Director of Medical Affairs, Senio...
Total Annual Compensation: $233.2K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $60.0K
Compensation as of Fiscal Year 2013.

medizone international inc (MZEI) Key Developments

Medizone International Inc. Auditor Raises 'Going Concern' Doubt

Medizone International Inc. filed its 10-K on Feb 28, 2014 for the period ending Dec 31, 2013. In this report its auditor, Tanner + Co., gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Medizone International, Inc. Announces Addition of David Esposito to Board of Directors

Medizone International Inc. announced the addition of David Esposito to the Board of Directors. The company makes this move in anticipation of full US regulatory approval of the company's AsepticSure(R) hospital disinfection system. David has tremendous commercial experience as a senior executive in both the pharmaceutical and medical diagnostic markets. Over a 15-year career with Merck & Co., David played key roles in sales, marketing, and commercial strategy.

New Ozone-Based Disinfection Technology Eradicates MRSA from Infected Hospital Rooms

Medizone International announced that it is using its AsepticSure system at the Quinte Health Care-Belleville General Hospital as part of the hospital's management of a recent outbreak of MRSA (Methicilllin-Resistant Staphylococcus Aureus) infections there. This move comes in the wake of Medizone having previously disinfected several patient care rooms at the facility in as little as 40 minutes treatment-time per room.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MZEI:US $0.16 USD +0.01

MZEI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MZEI.
View Industry Companies
 

Industry Analysis

MZEI

Industry Average

Valuation MZEI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIZONE INTERNATIONAL INC, please visit www.medizoneint.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.